Department of Molecular Science and Technology, Ajou University, Suwon 443-749, Korea.
Molecules. 2012 Nov 14;17(11):13503-29. doi: 10.3390/molecules171113503.
Toll-like receptors (TLRs) belong to a family of innate immune receptors that detect and clear invading microbial pathogens. Specifically intracellular TLRs such as TLR3, TLR7, TLR8 and TLR9 recognize nucleic acids such as double-stranded RNA, single-stranded RNA and CpG DNA respectively derived from microbial components. Upon infection, nucleic acid sensing TLRs signal within endosomal compartment triggering the induction of essential proinflammatory cytokines and type I interferons to initiate innate immune responses thereby leading to a critical role in the development of adaptive immune responses. Thus, stimulation of TLRs by nucleic acids is a promising area of research for the development of novel therapeutic strategies against pathogenic infection, allergies, malignant neoplasms and autoimmunity. This review summarizes the therapeutic applications of nucleic acids or nucleic acid analogues through the modulation of TLR signaling pathways.
Toll 样受体(TLRs)属于先天免疫受体家族,可识别和清除入侵的微生物病原体。具体来说,胞内 TLRs,如 TLR3、TLR7、TLR8 和 TLR9,分别识别源自微生物成分的双链 RNA、单链 RNA 和 CpG DNA 等核酸。感染后,核酸感应 TLRs 在内体腔内信号转导,触发必需的促炎细胞因子和 I 型干扰素的诱导,从而启动先天免疫反应,从而在适应性免疫反应的发展中发挥关键作用。因此,通过 TLRs 对核酸的刺激是开发针对致病感染、过敏、恶性肿瘤和自身免疫的新型治疗策略的一个有前途的研究领域。本综述总结了通过调节 TLR 信号通路,利用核酸或核酸类似物的治疗应用。